期刊文献+

胃肠道间质瘤中p-ERK和PTEN的表达及相互关系

Expressions of p-ERK and PTEN in Gastrointestinal Stromal Tumors and Their Interrelation
下载PDF
导出
摘要 目的:研究胃肠道间质瘤(GIST)中p-ERK和PTEN蛋白的表达,并探讨二者之间的关系。方法:采用免疫组织化学方法检测124例GIST患者及癌旁正常组织中p-ERK和PTEN的表达水平,并进行比较分析。结果:GIST组织中p-ERK蛋白表达阳性率84.68%,明显高于正常组织(16.13%);PTEN蛋白表达的阳性率60.48%,明显低于正常癌旁组织(100%),差异有显著性(P<0.01);p-ERK和PTEN的表达与性别、年龄以及组织学类型无关,与NIH分级、淋巴结转移及浸润深度有关;p-ERK与PTEN表达呈负相关。结论:p-ERK的高表达、PTEN的低表达共同促进了GIST的发展。 Objective:To investigate the expression of p-ERK,and PTEN proteins in gastrointestinal stromal tumors (GIST) and their interrelation. Methods:p-ERK and PTEN expressions in GIST and normal tissues of 124 patients were detected by using immunohistochemistry method,and the results were analized. Results:The positive rate of p-ERK protein expression in GIST tissue (84.68%) was significantly higher than that in normal tissues (16.113%),while the positive rate of PTEN protein expression in GIST tissue (60.48%) was lower than that in normal tissue (100%) with statistically significance (P0.01); Expressions of p-ERK and PTEN appeared to relate to NIH grading,lymphonode metastasis,and infiltration depth,but not to gender,age or tissue types. Expression of p-ERK and PTEN showed a negative correlation to each other. Conclusions:High expression of p-ERK,together with low expression of PTEN,propels the development of GIST,which may throw light to development of new anti-tumor drug and clinical tumor therapy.
出处 《贵阳医学院学报》 CAS 2010年第3期236-239,共4页 Journal of Guiyang Medical College
基金 辽宁省教育厅科研基金资助项目(2009A726)
关键词 胃肠肿瘤 有丝分裂素激活蛋白激酶激酶类 基因 肿瘤制 PTEN gastrointestinal neoplasms mitogen-activated protein kinase genes tumor suppressor PTEN
  • 相关文献

参考文献1

二级参考文献87

  • 1Mahimainathan L, Choudhury GG. Inactivation of plateletderived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase. J Biol Chem 2004; 279:15258-15268.
  • 2Myers MP, Pass I, Batty IH, et al. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 1998; 95:13513-13518.
  • 3Lee JO, Yang H, Georgescu MM, et al. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 1999; 99:323-334.
  • 4Gildea J J, Herlevsen M, Harding MA, et al. PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity. Oncogene 2004: 23:6788-6797.
  • 5Hlobilkova A, Guldberg P, Thullberg M, et al. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity. Exp Cell Res 2000; 256:571-577.
  • 6Shen WH, Balajee AS, Wang J, et al, Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 2007; 128:157-170.
  • 7Zhou XP, Gimm O, Hampel H, et al. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am J Patho12000; 157:1123-1128.
  • 8Mirmohammadsadegh A, Marini A, Nambiar S, et al. Epigenetic silencing of the PTEN gene in melanoma. Cancer Res 2006; 66:6546-6552.
  • 9Wiencke JK, Zheng S, Jelluma N, et al. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro Onco12007; 9:271-279.
  • 10Stambolic V, MacPherson D, Sas D, et al. Regulation of PTEN transcription by p53. Mol Cell 2001; 8:3174325.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部